How do I install the Ata Gh Ch Monitoring skill?

Run npx skillmds@latest add dromlakhani/ata-gh-ch-monitoring in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Ata Gh Ch Monitoring safe to use?

SkillMD's automated safety review verdict for this skill is PASS. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Ata Gh Ch Monitoring?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Ata Gh Ch Monitoring free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Ata Gh Ch Monitoring?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Ata Gh Ch Monitoring by dromlakhani

Name: Ata Gh Ch Monitoring
Rating: 4.2 (5 reviews)
Author: dromlakhani

Ata Gh Ch Monitoring

Monitors euthyroid adults with growth hormone deficiency (GHD) who are initiating GH replacement therapy for the development of central hypothyroidism (CH). Initiates levothyroxine (L-T4) if free thyroxine (fT4) falls below the laboratory reference range; triggers include GHD patient starting GH replacement.

dromlakhani Updated Aug 19, 2026 10 repo stars

File contents

Monitor for central hypothyroidism development in GH-treated patients

STEP 1 — Gather Information

Confirm GHD diagnosis (failed GH stimulation test or low IGF-1 with clinical features). Obtain baseline thyroid panel: fT4 and TSH. Verify euthyroid status (fT4 within lab reference range, TSH normal or low-normal). Record patient age, weight, and concomitant medications.

STEP 2 — Rule In / Rule Out

Is baseline fT4 below the laboratory reference range? If yes, patient already has CH; treat per CH guideline and stop this pathway. If fT4 is within reference range, proceed to monitor for CH development during GH therapy.

STEP 3 — Classify or Stratify

After initiating GH, measure fT4 at 6–8 weeks and then every 6 months. Classify result: fT4 decreased below reference range → CH developing; fT4 remains within reference range → no CH evident; continue routine monitoring.

STEP 4 — Decide

If fT4 is below reference range, start L-T4 therapy at approximately 1.6 µg/kg/d (adjust for age, weight, clinical context) and titrate to maintain fT4 in the mid-to-upper half of the reference range. If fT4 remains normal, continue GH therapy and repeat fT4 monitoring per schedule.

Clinical Guardrails / Mimics / Pitfalls

Do not rely on TSH alone to diagnose or monitor CH in GH-treated patients. Avoid initiating L-T4 empirically without a documented fT4 decrease below reference. Ensure adrenal insufficiency is evaluated or treated before starting L-T4 if not already addressed. Watch for overtreatment signs (elevated fT4, symptoms of hyperthyroidism) and adjust dose downward.

Concrete Clinical Example

A 45-year-old male with confirmed GHD (IGF-1 -2 SD, subnormal GH stimulation) begins GH 0.3 mg/day. Baseline fT4 1.2 ng/dl (ref 0.9–1.7), TSH 2.0 µIU/ml. At 8 weeks, fT4 0.8 ng/dl (below reference). He is started on L-T4 1.2 µg/kg/d (~80 µg daily); repeat fT4 in 6 weeks shows 1.1 ng/dl within target range.

Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2016-2118

---name: ata-gh-ch-monitoringdescription: Monitors euthyroid adults with growth hormone deficiency (GHD) who are initiating GH replacement therapy for the development of central hypothyroidism (CH). Initiates levothyroxine (L-T4) if free thyroxine (fT4) falls below the laboratory reference range; triggers include GHD patient starting GH replacement.---# Monitor for central hypothyroidism development in GH-treated patients## STEP 1 — Gather InformationConfirm GHD diagnosis (failed GH stimulation test or low IGF-1 with clinical features). Obtain baseline thyroid panel: fT4 and TSH. Verify euthyroid status (fT4 within lab reference range, TSH normal or low-normal). Record patient age, weight, and concomitant medications.## STEP 2 — Rule In / Rule OutIs baseline fT4 below the laboratory reference range? If yes, patient already has CH; treat per CH guideline and stop this pathway. If fT4 is within reference range, proceed to monitor for CH development during GH therapy.## STEP 3 — Classify or StratifyAfter initiating GH, measure fT4 at 6–8 weeks and then every 6 months. Classify result: fT4 decreased below reference range → CH developing; fT4 remains within reference range → no CH evident; continue routine monitoring.## STEP 4 — DecideIf fT4 is below reference range, start L-T4 therapy at approximately 1.6 µg/kg/d (adjust for age, weight, clinical context) and titrate to maintain fT4 in the mid-to-upper half of the reference range. If fT4 remains normal, continue GH therapy and repeat fT4 monitoring per schedule.## Clinical Guardrails / Mimics / PitfallsDo not rely on TSH alone to diagnose or monitor CH in GH-treated patients. Avoid initiating L-T4 empirically without a documented fT4 decrease below reference. Ensure adrenal insufficiency is evaluated or treated before starting L-T4 if not already addressed. Watch for overtreatment signs (elevated fT4, symptoms of hyperthyroidism) and adjust dose downward.## Concrete Clinical ExampleA 45-year-old male with confirmed GHD (IGF-1 -2 SD, subnormal GH stimulation) begins GH 0.3 mg/day. Baseline fT4 1.2 ng/dl (ref 0.9–1.7), TSH 2.0 µIU/ml. At 8 weeks, fT4 0.8 ng/dl (below reference). He is started on L-T4 1.2 µg/kg/d (~80 µg daily); repeat fT4 in 6 weeks shows 1.1 ng/dl within target range.**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, doi:10.1210/jc.2016-2118

Frequently asked questions